Structure-activity relation of NH2-terminal human parathyroid hormone fragments

It was already known that human parathyroid hormone (hPTH) regulates blood calcium levels through its NH2-terminal region. The normocalcemic function of hPTH is localized to the first 34 amino acids of the 84-amino acid hormone. Truncation of the first two amino acids results in complete loss of this function. However, the relationship between structural changes in truncated hPTH fragments and their biological activity remained unclear. This gap motivated the study of how stepwise NH2-terminal truncation affects the conformation of hPTH fragments. Prior research has shown that hPTH interacts via adenylate cyclase and phosphatidylinositol signaling pathways. No prior work had resolved how structural features like helical regions influence calcium regulation. This uncertainty drove the investigation into the conformational properties of hPTH fragments. The study aimed to clarify how structural changes correlate with functional outcomes.

The aim of this work was to examine how NH2-terminal truncation affects the structural and functional properties of hPTH fragments. The specific problem addressed was the loss of calcium regulatory activity when the NH2-terminal region is shortened. The motivation for this study came from the observation that truncation of the first two amino acids leads to a complete loss of normocalcemic function. The researchers sought to determine whether structural changes in hPTH fragments could explain this functional loss. They focused on fragments hPTH-(2-37), hPTH-(3-37), and hPTH-(4-37) in comparison to hPTH-(1-37). The study aimed to correlate structural features observed in solution with biological activity. The goal was to identify specific structural elements that are essential for maintaining calcium regulatory function.

The researchers used circular dichroism spectroscopy to assess secondary structure in solution. Two-dimensional nuclear magnetic resonance spectroscopy was employed to determine the spatial arrangement of amino acids. Restrained molecular dynamics calculations were applied to model the peptides' conformations under physiological conditions. The study compared four hPTH fragments: hPTH-(1-37), hPTH-(2-37), hPTH-(3-37), and hPTH-(4-37). Structural analysis focused on helical regions and hydrophobic interactions between specific amino acids. The team examined the NH2-terminal and COOH-terminal regions for structural changes. The peptides were analyzed in aqueous buffer to simulate near-physiological conditions. The methods allowed the researchers to correlate structural features with functional outcomes.

All hPTH fragments exhibited helical structures in solution. A defined loop region formed between His-14 and Ser-17 due to interactions between Leu-15 and Trp-23. A COOH-terminal helix from Met-18 to Leu-28 was observed in all peptides. The NH2-terminal helical structure was progressively lost with each truncation step. The loss of helical structure in the NH2-terminal region correlated with the loss of calcium regulatory activity. The structural integrity of the NH2-terminal helix was essential for maintaining function. The study found that the COOH-terminal helix remained intact regardless of truncation. These findings suggest that structural changes in the NH2-terminal region directly impact biological activity.

The authors propose that the loss of calcium regulatory activity in truncated hPTH fragments is due to structural changes in the NH2-terminal region. The study suggests that helical structure in the NH2-terminal part is necessary for maintaining function. The findings indicate that the NH2-terminal helix is a key determinant of biological activity. The researchers observed that the COOH-terminal helix remained stable across all fragments. The loss of helical structure in the NH2-terminal region correlates with the loss of normocalcemic function. The study supports the hypothesis that structural features are critical for hPTH activity. The authors suggest that the NH2-terminal helix is a functional determinant of hPTH. These conclusions are based on the observed structural and functional correlations.